Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.
Summary
Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, which could make the sector more b...
Description
Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, which could make the sector more b...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source